Xoma | XOMA - Resultado Líquido





Resultado Líquido Alterar Data
AbbVie USD 695M 1.12B 2026-03
Agenus USD -10.63M 74.49M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Ardelyx USD -407K 562K 2025-12
aTyr Pharma USD 24.56M 50.3M 2025-12
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Celldex Therapeutics USD -78.68M 2.63M 2026-03
Curis USD 19.36M 31.16M 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Incyte USD 303.33M 4.05M 2026-03
MacroGenics USD -14.16M 30.98M 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Prothena USD -21.59M 14.95M 2025-12
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Xoma USD -17.24M 33.23M 2024-09